MLH1 and Lynch syndrome: The clinical utility of TMB remains a contentious issue, but it may be wise to look at cases with high TMB, as almost all colorectal tumors arising in patients with Lynch syndrome and sporadic CRCs have high TMB due to MLH1 promoter hypermethylation [51,52].